Clinical Trials Logo

Clinical Trial Summary

The objective is to investigate neuro-anatomical correlates of the regulation of energy intake by means of functional MRI. Administration of glucose as well as fructose is followed by functional brain MRI, and findings are correlated with serum glucagon-like peptide 1 (GLP-1) levels as an endogenous satiety signal in obese humans.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02589613
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase N/A
Start date October 2013
Completion date June 2014

See also
  Status Clinical Trial Phase
Completed NCT02255812 - Taste Physiology in Healthy, Normal-weight Volunteers N/A
Completed NCT01918566 - The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity N/A
Completed NCT01875913 - The Power of Curiosity: Leveraging Curiosity to Motivate People to Complete Health Risk Assessments N/A
Recruiting NCT03604614 - Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer With Peritoneal Metastatis Phase 2
Completed NCT01615289 - Neural Effects of Green Tea Extract on Dorsolateral Prefrontal Cortex N/A
Completed NCT02902224 - Glucose and Fructose Stimulated Brain Activity in Obese Subjects Before and After Bariatric Surgery N/A